APA

Pitkänen H. H., Kärki M., Niinikoski H., Tanner L., Näntö-Salonen K., Pikta M., Kopatz W. F., Zuurveld M., Meijers J. C. M., Brinkman H. J. M. & Lassila R. (20190104). Abnormal coagulation and enhanced fibrinolysis due to lysinuric protein intolerance associates with bleeds and renal impairment. : Haemophilia : the official journal of the World Federation of Hemophilia.

Chicago

Pitkänen H H, Kärki M, Niinikoski H, Tanner L, Näntö-Salonen K, Pikta M, Kopatz W F, Zuurveld M, Meijers J C M, Brinkman H J M and Lassila R. 20190104. Abnormal coagulation and enhanced fibrinolysis due to lysinuric protein intolerance associates with bleeds and renal impairment. : Haemophilia : the official journal of the World Federation of Hemophilia.

Harvard

Pitkänen H. H., Kärki M., Niinikoski H., Tanner L., Näntö-Salonen K., Pikta M., Kopatz W. F., Zuurveld M., Meijers J. C. M., Brinkman H. J. M. and Lassila R. (20190104). Abnormal coagulation and enhanced fibrinolysis due to lysinuric protein intolerance associates with bleeds and renal impairment. : Haemophilia : the official journal of the World Federation of Hemophilia.

MLA

Pitkänen H H, Kärki M, Niinikoski H, Tanner L, Näntö-Salonen K, Pikta M, Kopatz W F, Zuurveld M, Meijers J C M, Brinkman H J M and Lassila R. Abnormal coagulation and enhanced fibrinolysis due to lysinuric protein intolerance associates with bleeds and renal impairment. : Haemophilia : the official journal of the World Federation of Hemophilia. 20190104.